In addition, other nuclear hormone receptors, such as the glucocorticoid receptor (GR), are able to activate a seemingly similar transcriptional program to the AR and may be a mechanism by which prostate cancer cells develop resistance to drugs that block AR signaling by disrupting the AR ligand interaction [57–60]. The gene discussed is AR; the disease is Familial prostate cancer.